EP3880678
KRISTALLAFORM AF P2X3 METÝL (S)-2-((2-(2,6-DÍFLÚOR-4-(METÝLKARBAMÓÝL)FENÝL)-7-METÝLIMÍDASÓ[1,2-A]PÝRIDÍN-3-ÝL)METÝL)MORFOLÍN-4-KARBOXÝLAT
:
EP einkaleyfi í gildi á Íslandi:
12.11.2019:
7.5.2025:
19884611.5
:
30.5.2025:
15.6.2025
:
11.11.2039:
11.11.2025
:
CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE
12.11.2019
7.5.2025
30.5.2025
15.6.2025
11.11.2025
:
GlaxoSmithKline Intellectual Property (No.3) Limited:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
:
GARCEAU, Denis:
Laval, QC H7V 4A7, CA
:
WENSLOW, Robert M.:
Laval, QC H7V 4A7, CA
:
PAYZA, Kemal:
Laval, QC H7V 4A7, CA
:
CHAURET, Nathalie:
Laval, QC H7V 4A7, CA
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
201862760307 P:
13.11.2018:
US
:
IB2019001199:
12.11.2019
:
C07D 471/04, A61K 31/5377, A61P 11/14, A61P 13/00, A61P 15/00, A61P 17/04, A61P 29/00